![Christopher Twomey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Twomey
Direktor/Vorstandsmitglied bei
TANDEM DIABETES CARE, INC.
Vermögen: 638 493 $ am 31.05.2026
Profil
Mr. Christopher J.
Twomey, CPA, is an Independent Director at Bionano Genomics, Inc., an Independent Director at Tandem Diabetes Care, Inc. and a Co-Manager at Twomey Family Investments LLC.
He is on the Board of Directors at Bionano Genomics, Inc. and Tandem Diabetes Care, Inc. Mr. Twomey was previously employed as an Independent Director by Cadence Pharmaceuticals, Inc., a Chief Financial Officer & Senior Vice President by BioSite, Inc., a Chief Financial Officer & Senior VP-Finance by New Biosite, Inc., and an Audit Manager by Ernst & Young LLP.
He also served on the board at Senomyx, Inc. He received his undergraduate degree from the University of California, Santa Barbara.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.05.2026 | 37’114 ( 0.05% ) | 638 361 $ | 31.05.2026 | |
| 14.05.2026 | 107 ( 0% ) | 133 $ | 31.05.2026 |
Aktive Positionen von Christopher Twomey
| Unternehmen | Position | Beginn |
|---|---|---|
| TANDEM DIABETES CARE, INC. | Direktor/Vorstandsmitglied | 01.07.2013 |
| BIONANO GENOMICS, INC. | Direktor/Vorstandsmitglied | 01.07.2018 |
Twomey Family Investments LLC | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Christopher Twomey
| Unternehmen | Position | Ende |
|---|---|---|
| SENOMYX INC. | Direktor/Vorstandsmitglied | 02.11.2018 |
| CADENCE PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 19.03.2014 |
Biosite, Inc. (Massachusetts)
 Biosite, Inc. (Massachusetts) Part of Abbott Laboratories, Biosite, Inc. is a consulting firm founded by Kenneth F. Buechler. The company, based in MA, specializes in strategic alliances, business development, and M&A advisory services within the biopharmaceutical field. The company has extensive expertise in therapeutic antibodies & proteins, oncology, autoimmune & infectious diseases, diagnostics, and specialty pharmaceuticals. Biosite, Inc. has been retained by various clients, including MedinCell S.A., Medin Cell Corp., Inc. & Undisclosed Mexican generics company, Avid Bioservices, Chiome Bioscience, Pfizer Animal Health, CombiChem, Kaken Pharmaceutical Co., Ltd., MediLite Diagnostics, Molecular Research Institute (Mri), and Structural Bioinformatics Inc. | Finanzdirektor/CFO | 01.06.2007 |
Alere San Diego, Inc.
 Alere San Diego, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical diagnostic instruments | Finanzdirektor/CFO | 01.01.2007 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Comptroller/Controller/Auditor | 01.03.1990 |
Ausbildung von Christopher Twomey
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
68
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical diagnostic instruments | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Senomyx, Inc.
 Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Discovers and develops novel flavors and taste modulators for the packaged food and beverage industry | Consumer Non-Durables |
Tandem Diabetes Care, Inc.
 Tandem Diabetes Care, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices for the treatment of diabetes | Health Technology |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bionano Genomics, Inc.
 Bionano Genomics, Inc. BiotechnologyHealth Technology Develops technologies for analysis of large biological molecules | Health Technology |
Biosite, Inc. (Massachusetts)
Biosite, Inc. (Massachusetts) Part of Abbott Laboratories, Biosite, Inc. is a consulting firm founded by Kenneth F. Buechler. The company, based in MA, specializes in strategic alliances, business development, and M&A advisory services within the biopharmaceutical field. The company has extensive expertise in therapeutic antibodies & proteins, oncology, autoimmune & infectious diseases, diagnostics, and specialty pharmaceuticals. Biosite, Inc. has been retained by various clients, including MedinCell S.A., Medin Cell Corp., Inc. & Undisclosed Mexican generics company, Avid Bioservices, Chiome Bioscience, Pfizer Animal Health, CombiChem, Kaken Pharmaceutical Co., Ltd., MediLite Diagnostics, Molecular Research Institute (Mri), and Structural Bioinformatics Inc. | |
Twomey Family Investments LLC |
Wählen Sie MarketScreener 
